Fortress Biotech (FBIO) Non-Current Assets (2016 - 2025)
Historic Non-Current Assets for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $62.9 million.
- Fortress Biotech's Non-Current Assets rose 5415.0% to $62.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $217.4 million, marking a year-over-year increase of 1968.81%. This contributed to the annual value of $53.9 million for FY2024, which is 662.92% up from last year.
- Per Fortress Biotech's latest filing, its Non-Current Assets stood at $62.9 million for Q3 2025, which was up 5415.0% from $49.5 million recorded in Q2 2025.
- Fortress Biotech's Non-Current Assets' 5-year high stood at $106.6 million during Q3 2021, with a 5-year trough of $40.8 million in Q3 2024.
- Over the past 5 years, Fortress Biotech's median Non-Current Assets value was $53.9 million (recorded in 2024), while the average stood at $60.8 million.
- As far as peak fluctuations go, Fortress Biotech's Non-Current Assets skyrocketed by 8342.33% in 2021, and later plummeted by 3851.9% in 2022.
- Fortress Biotech's Non-Current Assets (Quarter) stood at $50.0 million in 2021, then grew by 27.63% to $63.9 million in 2022, then dropped by 20.93% to $50.5 million in 2023, then grew by 6.63% to $53.9 million in 2024, then rose by 16.81% to $62.9 million in 2025.
- Its Non-Current Assets stands at $62.9 million for Q3 2025, versus $49.5 million for Q2 2025 and $51.2 million for Q1 2025.